Pathway Genomics IPO

pathway.com

Pathway Genomics is a biotechnology company focused on providing users with the most validated and personalized healthcare information delivered to any device, the company’s program with IBM Watson is the first of its kind to merge artificial intelligence and deep learning with precision medicine, applicable to both consumers and providers.

Founded2008
Total Funding to Date$127.23MM
Register for Details

For more details on financing and valuation for Pathway Genomics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Pathway Genomics Ticker Symbol

Pathway Genomics does not have a ticker symbol because this company got acquired.

Pathway Genomics Stock Price

The stock price for Pathway Genomics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Major Investors for Pathway Genomics

International Business Machines

Pathway Genomics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
1/5/2016 Series E-1 $40MM raised $XXX.XX $XXX.XX
11/12/2014 Series D $35.78MM raised $XXX.XX $XXX.XX
4/1/2014 Series C $36.51MM raised $XXX.XX $XXX.XX
7/15/2009 Series B $11.75MM raised $XXX.XX $XXX.XX
7/1/2009 Series A $3.19MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Pathway Genomics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector